State Street Corp Alx Oncology Holdings Inc Transaction History

State Street Corp

$2.36 Trillion
Q1 2025

A detailed history of State Street Corp transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, State Street Corp holds 718,853 shares of ALXO stock, worth $330,672. This represents 0.0% of its overall portfolio holdings.

Number of Shares

718,853

Previous 684,123 5.08%

Holding current value

$330,672

Previous $1.14 Million 61.03%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$0.62 - $1.86 $21,532 - $64,597	34,730 Added 5.08%	718,853 $445,000
Q4 2024 Feb 14, 2025	BUY	$1.21 - $1.87 $15,423 - $23,836	12,747 Added 1.9%	684,123 $1.14 Million
Q3 2024 Nov 14, 2024	SELL	$1.81 - $8.13 $61,849 - $277,810	-34,171 Reduced 4.84%	671,376 $1.22 Million
Q2 2024 Aug 14, 2024	BUY	$5.84 - $17.56 $885,811 - $2.66 Million	151,680 Added 27.39%	705,547 $4.25 Million
Q1 2024 May 15, 2024	BUY	$10.95 - $16.79 $573,462 - $879,309	52,371 Added 10.44%	553,867 $6.18 Million
Q4 2023 Feb 14, 2024	BUY	$4.81 - $15.38 $539,378 - $1.72 Million	112,137 Added 28.8%	501,496 $7.47 Million
Q3 2023 Nov 14, 2023	BUY	$4.19 - $7.35 $33,268 - $58,359	7,940 Added 2.08%	389,359 $1.87 Million
Q2 2023 Aug 14, 2023	SELL	$4.37 - $9.56 $54,734 - $119,739	-12,525 Reduced 3.18%	381,419 $2.86 Million
Q1 2023 May 15, 2023	BUY	$4.52 - $11.71 $1,780 - $4,613	394 Added 0.1%	393,944 $1.78 Million
Q4 2022 Feb 14, 2023	BUY	$9.51 - $12.95 $85,466 - $116,381	8,987 Added 2.34%	393,550 $4.44 Million
Q3 2022 Nov 15, 2022	BUY	$8.23 - $15.14 $236,678 - $435,396	28,758 Added 8.08%	384,563 $3.68 Million
Q2 2022 Aug 15, 2022	SELL	$5.89 - $19.46 $10.5 Million - $34.6 Million	-1,777,939 Reduced 83.32%	355,805 $2.88 Million
Q1 2022 May 16, 2022	BUY	$13.65 - $22.06 $9.44 Million - $15.3 Million	691,410 Added 47.94%	2,133,744 $36.1 Million
Q4 2021 Feb 14, 2022	BUY	$21.49 - $74.4 $12.5 Million - $43.2 Million	580,779 Added 67.41%	1,442,334 $31 Million
Q3 2021 Nov 15, 2021	SELL	$52.51 - $80.91 $10.2 Million - $15.6 Million	-193,322 Reduced 18.33%	861,555 $63.6 Million
Q2 2021 Aug 16, 2021	BUY	$52.2 - $75.23 $6.65 Million - $9.59 Million	127,438 Added 13.74%	1,054,877 $57.7 Million
Q1 2021 May 17, 2021	BUY	$62.84 - $87.68 $34.2 Million - $47.8 Million	544,900 Added 142.44%	927,439 $68.4 Million
Q4 2020 Feb 16, 2021	BUY	$34.11 - $112.26 $9.18 Million - $30.2 Million	269,016 Added 236.97%	382,539 $33 Million
Q3 2020 Nov 10, 2020	BUY	$29.36 - $47.1 $3.33 Million - $5.35 Million	113,523 New	113,523 $4.28 Million

Others Institutions Holding ALXO

# of Institutions

Shares Held

35.3M

Call Options Held

34K

Put Options Held

36.9K

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $18.7M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Alx Oncology Holdings Inc Transaction History